[Assessment of blood eosinophil count in respiratory disease from primary care].

Most physicians in general, and family physicians in particular, are familiar with certain parameters when ordering a hematological study, such as hemoglobin (including hematocrit and its features), leukocytes (including lymphocytes) and platelets. Nevertheless, there are two values that we use to overlook which are eosinophils and basophils. Specifically, eosinophils have a tendency to increase with allergic pathology.

Susceptibility to endemic Aedes-borne viruses among pregnant women in Risaralda, Colombia.

Objectives: Aedes-borne viruses (ABV) affect humans on every inhabited continent and frequently cause epidemics. Recent epidemics of chikungunya and Zika viruses (ZIKV) highlight that preparedness for future epidemics requires assessment of susceptibility, particularly among high-risk groups. We sought to determine immunity against the three major circulating ABV among pregnant women in an ABV-endemic area of Colombia.

[Impact of an interactive web application on the improvement of cardiovascular risk factors control. Control-RCV project].

Objective: To ascertain the utility of an interactive web application in the improvement of cardiovascular (CV) risk control.

Methods: Observational study in which primary care physicians consecutively included high/very high CV risk patients with at least one of the following risk factors poorly controlled: hypertension, dyslipidemia or diabetes. After the introduction of data, the application generated a report comparing the recommended and the real targets.

Paederus dermatitis - A bibliometric analysis of an emerging disease in travelers.

Not available.

Anaerobic Bacteremias in Left Ventricular Assist Devices and Advanced Heart Failure.

Left ventricular assisted devices (LVADs) have revolutionized the treatment of advanced heart failure, providing meaningful increases in survival, functional capacity, and quality of life. There are two categories of LVADs patients: (1) bridge-to-transplant and (2) destination therapy. Advanced heart failure and destination LVADs often carry a poor prognosis.